Register for Upcoming Webinar on DEC. 8 @ 11AM
2025 China NMPA Bluebook is here:
Share:
Companies in non-healthcare industry in China are eager to get into healthcare sector from both supply and demand side. Pharmaceutical companies in China are eager to diversity and transform its drug portfolio. From R&D, manufacturing, distribution, to private physician groups, clinics and hospitals, the market is dynamically changing.
More Info., Click Companies in non-healthcare industry in China are eager to get into healthcare sector
One giant leap from China medical device regulators—the NMPA began
The NMPA Standards Management Center published the “First Batch of
An amendment of the Regulation on the Supervision and Administration
On January 25, 2021 the China National Health Commission issued
Before July 21, 2021 the devices and drugs from Hongkong
Grace Palma, CEO of China Med Device, is invited to
Email: info@chinameddevice.com
Phone: 978-390-4453
USA Office:
1 Broadway, 14th Floor
Cambridge, MA 02142
CHINA Office:
Suite 1702C, Beijing Hailongshiyou Building, Chaoyang District, Beijing